El-Araby; Moustafa E.
Patent Applications and Registrations
Patent applications and USPTO patent grants for El-Araby; Moustafa E..The latest application filed is for "method for making propenamide compound".
Company Profile
15.27.18
- El-Araby; Moustafa E. - Jeddah SA
- El-Araby; Moustafa E. - Cairo EG
- El-Araby; Moustafa E. - Plainsboro NJ
Patent Activity
| Patent | Date |
|---|---|
| 3-vinylquinolines as cancer cells inhibitors Grant 11,345,692 - Ibrahim , et al. May 31, 2 | 2022-05-31 |
| Method for treating stomach cancer Grant 11,325,885 - El-Araby , et al. May 10, 2 | 2022-05-10 |
| Method for treating a patient having a colon cancer Grant 11,312,680 - El-Araby , et al. April 26, 2 | 2022-04-26 |
| Method for making propenamide compound Grant 11,312,694 - El-Araby , et al. April 26, 2 | 2022-04-26 |
| Method For Making Propenamide Compound App 20220033368 - EL-ARABY; Moustafa E. ; et al. | 2022-02-03 |
| Method Of Treating Colorectal Cancer App 20220009896 - EL-ARABY; Moustafa E. ; et al. | 2022-01-13 |
| Chemotherapeutic oxazolone derivatives and pharmaceutical compositions thereof Grant 11,220,485 - El-Araby , et al. January 11, 2 | 2022-01-11 |
| Method for making anti-cancer compounds Grant 11,214,537 - El-Araby , et al. January 4, 2 | 2022-01-04 |
| Method of treating colorectal cancer Grant 11,214,556 - El-Araby , et al. January 4, 2 | 2022-01-04 |
| Method For Treating A Patient Having A Colon Cancer App 20210395187 - EL-ARABY; Moustafa E. ; et al. | 2021-12-23 |
| Method For Treating Stomach Cancer App 20210380526 - EL-ARABY; Moustafa E. ; et al. | 2021-12-09 |
| Anticancer compounds, pharmaceutical compositions thereof, and a method of treating cancer Grant 11,180,458 - El-Araby , et al. November 23, 2 | 2021-11-23 |
| Anti-cancer compounds having oxazolone derivation Grant 11,174,233 - El-Araby , et al. November 16, 2 | 2021-11-16 |
| Chemotherapeutic Oxazolone Derivatives And Pharmaceutical Compositions Thereof App 20210340110 - EL-ARABY; Moustafa E. ; et al. | 2021-11-04 |
| Method For Making Anti-cancer Compounds App 20210340097 - EL-ARABY; Moustafa E. ; et al. | 2021-11-04 |
| Bis-propenamide compounds and methods of treating cancer Grant 11,155,528 - El-Araby , et al. October 26, 2 | 2021-10-26 |
| Pharmaceutical composition for treating cancer Grant 11,142,493 - El-Araby , et al. October 12, 2 | 2021-10-12 |
| Method for treating a patient having cancer Grant 11,136,288 - El-Araby , et al. October 5, 2 | 2021-10-05 |
| Method For Treating A Patient Having Cancer App 20210188765 - EL-ARABY; Moustafa E. ; et al. | 2021-06-24 |
| Anticancer Compounds, Pharmaceutical Compositions Thereof, And A Method Of Treating Cancer App 20210139434 - EL-ARABY; Moustafa E. ; et al. | 2021-05-13 |
| Bis-propenamide Compounds And Methods Of Treating Cancer App 20210122721 - EL-ARABY; Moustafa E. ; et al. | 2021-04-29 |
| Cytotoxic compounds, pharmaceutical compositions thereof, and methods of treating cancer Grant 10,988,439 - El-Araby , et al. April 27, 2 | 2021-04-27 |
| Imidazole-based compounds as hepatitis C virus inhibitors Grant 10,959,987 - El-Araby , et al. March 30, 2 | 2021-03-30 |
| Substituted [1,2,4]triazolo[4,3-a]pyrazines as antidiabetics Grant 10,894,794 - Omar , et al. January 19, 2 | 2021-01-19 |
| Chemosensitization of resistant Pseudomonas aeruginosa by synthetically related compounds Grant 10,888,566 - El-Araby , et al. January 12, 2 | 2021-01-12 |
| 3-vinylquinolines as cancer cells inhibitors Grant 10,882,852 - Ibrahim , et al. January 5, 2 | 2021-01-05 |
| Amide Group-containing Compounds And Use For Cancer Treatment App 20200385337 - El-Araby; Moustafa E. ; et al. | 2020-12-10 |
| Cytotoxic Compounds, Pharmaceutical Compositions Thereof, And Methods Of Treating Cancer App 20200385336 - El-Araby; Moustafa E. ; et al. | 2020-12-10 |
| Compounds For Inhibiting Ns3 And Compositions Containing The Inhibited Protein App 20200368204 - EL-ARABY; Moustafa E. ; et al. | 2020-11-26 |
| Composition And Method For Treating A Patient Having Liver Cirrhosis App 20200369727 - EL-ARABY; Moustafa E. ; et al. | 2020-11-26 |
| Pharmaceutical composition and method of treating cancer Grant 10,844,022 - El-Araby , et al. November 24, 2 | 2020-11-24 |
| Amide group-containing compounds and use for cancer treatment Grant 10,844,007 - El-Araby , et al. November 24, 2 | 2020-11-24 |
| Chemosensitization of resistant Pseudomonas aeruginosa by synthetically related compounds Grant 10,842,795 - El-Araby , et al. November 24, 2 | 2020-11-24 |
| Pharmaceutical composition with cytotoxic activity on colorectal cancer cells Grant 10,836,736 - El-Araby , et al. November 17, 2 | 2020-11-17 |
| Compounds for inhibiting NS3 and compositions containing the inhibited protein Grant 10,821,096 - El-Araby , et al. November 3, 2 | 2020-11-03 |
| Imidazole-based Compounds As Hepatitis C Virus Inhibitors App 20200323822 - EL-ARABY; Moustafa E. ; et al. | 2020-10-15 |
| Peptide Inhibitors Of Hcv Ns3/4a Protease Comprising Non-proteinogenic Amino Residues App 20200308228 - EL-ARABY; Moustafa E. ; et al. | 2020-10-01 |
| Antidiabetic compounds Grant 10,683,267 - Omar , et al. | 2020-06-16 |
| Antidiabetic compounds Grant 10,654,800 - Omar , et al. | 2020-05-19 |
| Protein kinase and phosphatase inhibitors Grant 8,088,768 - Hangauer, Jr. , et al. January 3, 2 | 2012-01-03 |
| Protein Kinase And Phosphatase Inhibitors App 20110028474 - Hangauer, JR.; David G. ; et al. | 2011-02-03 |
| Protein kinase and phosphatase inhibitors and methods for designing them Grant 7,772,216 - Hangauer, Jr. , et al. August 10, 2 | 2010-08-10 |
| Protein kinase and phosphatase inhibitors and methods for designing them Grant 7,005,445 - Hangauer, Jr. , et al. February 28, 2 | 2006-02-28 |
| Protein kinase and phosphatase inhibitors and methods for designing them App 20060030544 - Hangauer; David G. JR. ; et al. | 2006-02-09 |
| Protein kinase and phosphatase inhibitors and methods for designing them App 20030166615 - Hangauer, David G. JR. ; et al. | 2003-09-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 